BSE filing, NSE: SAINIK. Summary written from the filing by ALFA Finder's alert engine.
Sainik Finance & Industries Ltd: key numbers
- Share price
- ₹36.40
- Market cap
- ₹39.60 Cr
- Revenue (annual)
- ₹16.88 Cr
- Net profit (annual)
- ₹4.17 Cr
- P/E (TTM)
- 9.6×Sector 19.7×
- Promoter holding
- 70.25%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sainik Finance & Industries Ltd
All →Sainik Finance & Industries Management Change
Sainik Finance & Industries Ltd shareholders approved the appointment of Sh. Somvir Sindhu as a Non-Executive Non-Independent Director during the 34th Annual General Meeting.
Sainik Finance & Industries Annual General Meeting
Sainik Finance & Industries Limited conducted its 34th Annual General Meeting on September 29, 2026. Shareholders considered the adoption of financial statements and approved related party transactions.
Sainik Finance & Industries Dividend
Sainik Finance & Industries declared a 5% interim dividend (₹0.50/share) for FY 2025-26. Record date is October 1, 2026; payment within 30 days.
Sainik Finance & Industries Promoter Buying (Off-Market): ₹5.35 Cr
Sainik Finance promoter group completed an off-market inter-se transfer of 13.16 lakh shares at Rs.40.62 each, valued ~Rs.5.35 Crore. Acquirer group stake rose from 32.45% to 44.55%.
- Value
- ₹5.35 Cr
- Promoter stake change
- +12.10%
Sainik Finance & Industries Board Meeting Date
Sainik Finance & Industries Ltd will hold a Board Meeting on September 23, 2026, to consider declaring an interim dividend for the financial year ending March 2026.
Sainik Finance & Industries Promoter Buying (Off-Market): ₹0.03 Cr
Ekta Sindhu (Promoter Group) acquired 6,200 shares from Maj. Niranjan Singh via an inter-se transfer, valued at ₹0.03 Crore. This disclosure confirms the off-market transaction.
- Value
- ₹0.03 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.